aspartate-beta-hydroxamate has been researched along with HIV Coinfection in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grange, JM; Hamedi-Sangsari, F; Malley, SD; Vila, JR | 1 |
Hamedi-Sangsari, F; Lockhart, BP; Privat, A; Vignon, J; Vila, J | 1 |
2 other study(ies) available for aspartate-beta-hydroxamate and HIV Coinfection
Article | Year |
---|---|
Synergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2',3'-dideoxyinosine in infected resting human lymphocytes.
Topics: Antiviral Agents; Asparagine; Aspartic Acid; Cell Survival; Cells, Cultured; Didanosine; Drug Synergism; HIV Infections; Humans; Hydroxyurea; In Vitro Techniques; Lymphocyte Activation; Lymphocytes; Virus Replication; Zalcitabine; Zidovudine | 1994 |
Neurotoxic effect of the anti-HIV drug D-aspartate beta-hydroxamate for rat primary neuronal cultures: attenuation by N-methyl-D-aspartate (NMDA) antagonists.
Topics: Animals; Asparagine; Cells, Cultured; Cerebral Cortex; HIV Infections; N-Methylaspartate; Neurons; Rats; Rats, Sprague-Dawley | 1993 |